Crinetics Pharmaceuticals Inc

NASDAQ:CRNX   11:38:17 AM EDT
16.79
-0.31 (-1.81%)
Earnings Announcements

Crinetics Pharmaceuticals Reports Q4 Revenue Of $1.1 Million

Published: 03/30/2022 20:15 GMT
Crinetics Pharmaceuticals Inc (CRNX) - Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results.
Q4 Revenue $1.1 Million.
Unrestricted Cash, Cash Equivalents and Investments Totaled $333.7 Million As of December 31, 2021.
Qtrly Loss per Share $0.68.
Revenue is expected to be $0.43 Million
Adjusted EPS is expected to be -$0.64

Next Quarter Revenue Guidance is expected to be $0.65 Million
Next Quarter EPS Guidance is expected to be -$0.66

More details on our Analysts Page.